BR112014013371A2 - formulações injetáveis de moxidectina de longa ação e novas formas de cristal de moxidectina - Google Patents

formulações injetáveis de moxidectina de longa ação e novas formas de cristal de moxidectina

Info

Publication number
BR112014013371A2
BR112014013371A2 BR112014013371A BR112014013371A BR112014013371A2 BR 112014013371 A2 BR112014013371 A2 BR 112014013371A2 BR 112014013371 A BR112014013371 A BR 112014013371A BR 112014013371 A BR112014013371 A BR 112014013371A BR 112014013371 A2 BR112014013371 A2 BR 112014013371A2
Authority
BR
Brazil
Prior art keywords
moxidectin
long
crystal forms
new crystal
formulations
Prior art date
Application number
BR112014013371A
Other languages
English (en)
Other versions
BR112014013371B1 (pt
Inventor
Ma Baoqing
Yang Chunhua
Clark Chapman Robert
Mancini Cady Susan
Jain Uday
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Priority to BR122020002199-3A priority Critical patent/BR122020002199B1/pt
Publication of BR112014013371A2 publication Critical patent/BR112014013371A2/pt
Publication of BR112014013371B1 publication Critical patent/BR112014013371B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo da patente de invenção para: “formulações injetáveis de moxidectina de longa ação e novas formas de cristal de moxidectina”. esta invenção fornece novas formas antiparasíticas e pesticidas de moxidectina, incluindo um implante polimérico de longa ação. os compostos resultantes podem ser usados em composições veterinárias que são usadas no tratamento, controle e prevenção de infecções por endo e ectoparasitas em animais.
BR112014013371A 2011-12-02 2012-11-30 formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina BR112014013371B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122020002199-3A BR122020002199B1 (pt) 2011-12-02 2012-11-30 formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161566336P 2011-12-02 2011-12-02
PCT/US2012/067215 WO2013082373A1 (en) 2011-12-02 2012-11-30 Long-acting injectable moxidectin formulations and novel moxidectin crystal forms

Publications (2)

Publication Number Publication Date
BR112014013371A2 true BR112014013371A2 (pt) 2017-06-13
BR112014013371B1 BR112014013371B1 (pt) 2020-04-07

Family

ID=47324470

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112014013371A BR112014013371B1 (pt) 2011-12-02 2012-11-30 formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina
BR122020002199-3A BR122020002199B1 (pt) 2011-12-02 2012-11-30 formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122020002199-3A BR122020002199B1 (pt) 2011-12-02 2012-11-30 formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina

Country Status (15)

Country Link
US (2) US8715711B2 (pt)
EP (2) EP2785719B1 (pt)
CN (2) CN104053660B (pt)
AU (4) AU2012345813B2 (pt)
BR (2) BR112014013371B1 (pt)
CA (2) CA2857958C (pt)
DK (2) DK2785719T3 (pt)
ES (1) ES2659159T3 (pt)
HK (2) HK1201264A1 (pt)
HU (1) HUE036441T2 (pt)
MX (1) MX358476B (pt)
PL (1) PL2785719T3 (pt)
PT (2) PT3351546T (pt)
WO (1) WO2013082373A1 (pt)
ZA (1) ZA201404122B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2846820T3 (es) * 2013-04-12 2021-07-29 Zoetis Services Llc Composición de lactonas macrocíclicas, levamisol, un aminoazúcar y un agente antiparasitario adicional
CN103405388B (zh) * 2013-08-21 2015-04-08 成都乾坤动物药业有限公司 一种可湿性莫西菌素固体分散粉及其制备方法和用途
FR3028314B1 (fr) * 2014-11-07 2016-12-23 Aircelle Sa Procede de caracterisation du vieillissement thermique de materiaux composites, en particulier de materiaux composites a matrice organique
SG10201912724SA (en) * 2015-04-08 2020-02-27 Boehringer Ingelheim Animal Health Usa Inc Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
CA3046275A1 (en) 2016-12-09 2018-06-14 Bayer Animal Health Gmbh Pharmaceutical preparation and method for its manufacture
EP3609470B1 (en) * 2017-04-13 2023-11-22 Ceva Santé Animale Implant for treating parasites infestations
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
CA3082048A1 (en) * 2017-11-23 2019-05-31 Ceva Sante Animale Composition containing moxidectin for treating parasites infestations
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
CH604517A5 (pt) 1976-08-19 1978-09-15 Ciba Geigy Ag
US5089490A (en) 1977-04-02 1992-02-18 Hoechst Aktiengesellschaft Cephem derivatives
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4457920A (en) 1981-09-03 1984-07-03 Merck & Co., Inc. 4a-Substituted avermectin compounds
US4423209A (en) 1982-02-26 1983-12-27 Merck & Co., Inc. Processes for the interconversion of avermectin compounds
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
DE3235931A1 (de) 1982-09-29 1984-03-29 Bayer Ag, 5090 Leverkusen Koeder zur bekaempfung von ungeziefer
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
US5106994A (en) 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
EP0165900A3 (de) 1984-06-08 1986-05-28 Ciba-Geigy Ag Neue Lactone, Verfahren zu ihrer Herstellung und ihre Verwendung in der Schädlingsbekämpfung
EP0179022B1 (de) 1984-10-18 1990-11-07 Ciba-Geigy Ag Benzoylphenylharnstoffe
DE3681465D1 (pt) 1985-02-04 1991-10-24 Nihon Bayer Agrochem K.K., Tokio/Tokyo, Jp
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
AR243191A1 (es) 1986-03-25 1993-07-30 Sankyo Co Procedimiento para preparar compuestos de macrolida
CA1296329C (en) 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
EP0252879B1 (de) 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US4831016A (en) 1986-10-31 1989-05-16 Merck & Co., Inc. Reduced avermectin derivatives
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4806527A (en) 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (en) 1987-11-03 1994-04-06 Beecham Group Plc Intermediates for the preparation of anthelmintic macrolide antibiotics
US4895837A (en) 1988-01-29 1990-01-23 Merck & Co., Inc. Avermectin derivatives
US4873224A (en) 1988-05-23 1989-10-10 Merck & Co., Inc. Avermectin derivatives
US4906619A (en) 1988-07-22 1990-03-06 Merck & Co., Inc. Alkyl avermectin derivatives
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5057499A (en) 1989-06-02 1991-10-15 Merck & Co. Inc. Avermectin derivatives
US5030622A (en) 1989-06-02 1991-07-09 Merck & Co., Inc. Avermectin derivatives
US5023241A (en) 1989-07-31 1991-06-11 Merck & Co., Inc. Avermectin derivatives
US4988824A (en) 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds
US5830875A (en) 1989-10-30 1998-11-03 Merck & Co., Inc. 24-and 25-substituted avermectin and milbemycin derivatives
US5055454A (en) 1989-10-30 1991-10-08 Merck & Co., Inc. 13-epi-avermectin derivatives useful as antiparasitic agents
IE904606A1 (en) 1989-12-21 1991-07-03 Beecham Group Plc Novel products
US5169839A (en) 1990-05-11 1992-12-08 Merck & Co., Inc. Derivatives of 3'- and 3"-o-desmethyl avermectin compounds, compositions and methods of treating melmintic and parasitic infections
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5208222A (en) 1991-03-28 1993-05-04 Merck & Co., Inc. 4"-and 4'-alkylthio avermectin derivatives
WO1992022555A1 (en) 1991-06-17 1992-12-23 Beecham Group Plc Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
US5262400A (en) 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US5162363A (en) 1992-03-18 1992-11-10 Merck & Co., Inc. 23-nor-23-thia avermectin analogs are active anthelmintic agents
US5244879A (en) 1992-03-18 1993-09-14 Merck & Co., Inc. 23-nor-23-oxa avermectin analogs are active anthelmintic agents
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
TW334436B (en) 1995-07-21 1998-06-21 Upjohn Co Antiparasitic marcfortines and paraherquamides
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
FR2752525B1 (fr) 1996-08-20 2000-05-05 Rhone Merieux Procede de lutte contre les myiases des cheptels bovins et ovins et compositions pour la mise en oeuvre de ce procede
US5885607A (en) 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
FR2750861B1 (fr) 1996-07-11 1998-12-24 Rhone Merieux Procedes d'elimination des parasites, et notamment des ectoparasites de vertebres, notamment de mammiferes et compositions pour la mise en oeuvre de ce procede
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
ES2359973T3 (es) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
AU5261301A (en) 2000-04-27 2001-11-12 Sankyo Co 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
US6399786B1 (en) 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
AU2001278694A1 (en) 2000-08-09 2002-02-18 The Kitasato Institute Avermectin derivatives
AUPR602501A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
TW200409760A (en) 2002-09-11 2004-06-16 Novartis Ag Organic compounds
US7326428B2 (en) 2002-12-18 2008-02-05 Evergreen Innovation Partners I, Lp Multi-compartment container and lid assembly
US7348417B2 (en) 2003-08-07 2008-03-25 Wyeth Method of purifying moxidectin through crystallization
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
JP4883296B2 (ja) 2004-03-05 2012-02-22 日産化学工業株式会社 イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
AU2006326449A1 (en) 2005-12-14 2007-06-21 E. I. Du Pont De Nemours And Company Isoxazolines for controlling invertebrate pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
EP2181100A2 (en) 2007-04-10 2010-05-05 Bayer CropScience AG Insecticidal aryl isoxazoline derivatives
ES2714578T3 (es) 2007-05-15 2019-05-29 Merial Inc Compuestos de ariloazol-2-il cianoetilamino, procedimiento de fabricación y procedimiento de utilización de los mismos
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
PL2957284T3 (pl) 2007-06-27 2018-08-31 E. I. Du Pont De Nemours And Company Sposób zwalczania szkodników zwierzęcych
PT2170321E (pt) 2007-06-29 2013-08-01 Zoetis Llc Combinação anti-helmíntica
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用

Also Published As

Publication number Publication date
ES2659159T3 (es) 2018-03-14
PL2785719T3 (pl) 2018-03-30
AU2017200177A1 (en) 2017-02-02
CA3082432C (en) 2023-01-03
MX2014006601A (es) 2015-03-05
PT3351546T (pt) 2024-03-07
AU2017268548A1 (en) 2018-01-04
CN104053660B (zh) 2016-12-28
HK1201264A1 (en) 2015-08-28
CA3082432A1 (en) 2013-06-06
CA2857958A1 (en) 2013-06-06
CN105232529B (zh) 2018-11-23
NZ626149A (en) 2016-06-24
AU2012345813B2 (en) 2017-02-02
CA2857958C (en) 2020-08-25
US20140323559A1 (en) 2014-10-30
HK1256641A1 (zh) 2019-09-27
US20130143956A1 (en) 2013-06-06
EP3351546A1 (en) 2018-07-25
DK3351546T3 (da) 2024-04-29
ZA201404122B (en) 2015-09-30
CN105232529A (zh) 2016-01-13
AU2017268548B2 (en) 2019-09-19
AU2019229407A1 (en) 2019-10-03
US9044453B2 (en) 2015-06-02
AU2017200177B2 (en) 2017-11-23
WO2013082373A1 (en) 2013-06-06
PT2785719T (pt) 2018-02-08
EP2785719B1 (en) 2017-11-08
EP3351546B1 (en) 2024-02-14
EP2785719A1 (en) 2014-10-08
MX358476B (es) 2018-08-22
CN104053660A (zh) 2014-09-17
AU2012345813A1 (en) 2014-07-03
HUE036441T2 (hu) 2018-07-30
US8715711B2 (en) 2014-05-06
DK2785719T3 (en) 2017-12-04
BR112014013371B1 (pt) 2020-04-07
BR122020002199B1 (pt) 2021-01-19

Similar Documents

Publication Publication Date Title
BR112014013371A2 (pt) formulações injetáveis de moxidectina de longa ação e novas formas de cristal de moxidectina
NI201700011A (es) 2-(morfolin-4-il)-1,7-naftiridinas.
ECSP19030002A (es) 1,2,4-triazolonas 2,4,5-trisustituidas
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
CO2018002060A2 (es) Compuestos farmacéuticos
BR112017018368A2 (pt) composições contendo rna para o tratamento de doenças tumorais
CL2015003346A1 (es) Composiciones de cenicriviroc y métodos para realizarlas y utilizarlas
BR112013018920A2 (pt) composições de nanopartículas, formulações destas e seus usos
AR104984A1 (es) Compuestos selectivos para pyy y sus usos
HN2008000311A (es) Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
CR20140113A (es) Imidazopiridazinas sustituidas con amino
BRPI1002601E2 (pt) composição nanoestruturada de uso veterinário para administração de fármacos
DOP2016000253A (es) Nuevos compuestos
UY31539A1 (es) Agentes antelminticos y su uso
BR112018075162A2 (pt) composições para higiene bucal
CO2019011877A2 (es) Nuevos derivados de pirazol bicíclicos
CO6771450A2 (es) Ureas asimétricas y usos médicos de las mismas
CR20160235A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CO2019011546A2 (es) Compuestos y métodos para el tratamiento de enfermedades parasitarias
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
ECSP13013075A (es) Método de tratamiento de la fiebre dengue
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
BR112014024033A8 (pt) Formulação vesicular, método para o tratamento da rosácea e uso de um ou mais fosfo, sulfolipídios e surfactantes
PA8661101A1 (es) Compuestos antihelminticos

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: MERIAL LIMITED (US)

B25A Requested transfer of rights approved

Owner name: MERIAL, INC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2012, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US)